» Articles » PMID: 15144949

The Development of Proteasome Inhibitors As Anticancer Drugs

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2004 May 18
PMID 15144949
Citations 274
Authors
Affiliations
Soon will be listed here.
Abstract

The ubiquitin-proteasome pathway plays a central role in the targeted destruction of cellular proteins, including cell cycle regulatory proteins. Because these pathways are critical for the proliferation and survival of all cells, and in particular cancerous cells, proteasome inhibition is a potentially attractive anticancer therapy. Based on encouraging cytotoxic activity, bortezomib was the first proteasome inhibitor to be evaluated in clinical trials. Efficacy and safety results from a phase 2 clinical trial contributed to approval of bortezomib for use in patients with relapsed and refractory multiple myeloma who have received at least 2 prior therapies and have demonstrated disease progression on their last therapy.

Citing Articles

Prognostic Value of PSMB5 and Correlations with LC3II and Reactive Oxygen Species Levels in the Bone Marrow Mononuclear Cells of Bortezomib-Resistant Multiple Myeloma Patients.

Plakoula E, Kalampounias G, Alexis S, Verigou E, Kourakli A, Zafeiropoulou K Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852147 PMC: 11763810. DOI: 10.3390/cimb47010032.


The Ubiquitin Tale: Current Strategies and Future Challenges.

Upadhyay A, Joshi V ACS Pharmacol Transl Sci. 2024; 7(9):2573-2587.

PMID: 39296276 PMC: 11406696. DOI: 10.1021/acsptsci.4c00278.


The Role of S-Glutathionylation in Health and Disease: A Bird's Eye View.

Federici L, Masulli M, De Laurenzi V, Allocati N Nutrients. 2024; 16(16).

PMID: 39203889 PMC: 11357436. DOI: 10.3390/nu16162753.


Clickable Probes for Pathogen Proteasomes: Synthesis and Applications.

Liu L, Lucero B, Manriquez-Rodriguez C, Francisco K, Teixeira T, Yohannan D ACS Omega. 2024; 9(32):34829-34840.

PMID: 39157084 PMC: 11325529. DOI: 10.1021/acsomega.4c04316.


Exploring the origins of neurodevelopmental proteasomopathies associated with cardiac malformations: are neural crest cells central to certain pathological mechanisms?.

Vignard V, Baruteau A, Toutain B, Mercier S, Isidor B, Redon R Front Cell Dev Biol. 2024; 12:1370905.

PMID: 39071803 PMC: 11272537. DOI: 10.3389/fcell.2024.1370905.